IDEAYA Biosciences, Inc. Common Stock Earnings Dividend

IDEAYA Biosciences, Inc. Common Stock’s revenue jumped +Inf% since last year same period to $8.86Mn in the Q2 2026. On a quarterly growth basis, IDEAYA Biosciences, Inc. Common Stock has generated 35.02% jump in its revenue since last 3-months.

IDEAYA Biosciences, Inc. Common Stock’s net profit fell -45.12% since last year same period to $-112.45Mn in the Q2 2026. On a quarterly growth basis, IDEAYA Biosciences, Inc. Common Stock has generated -14.12% fall in its net profits since last 3-months.

IDEAYA Biosciences, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -1269.64% in the Q2 2026. On a quarterly growth basis, IDEAYA Biosciences, Inc. Common Stock has generated 15.48% jump in its net profit margins since last 3-months.

IDEAYA Biosciences, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -1.18 - a -20.41% fall from last quarter’s estimates.

IDEAYA Biosciences, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -1.18.

IDEAYA Biosciences, Inc. Common Stock’s earning per share (EPS) fell -38.64% since last year same period to -1.22 in the Q2 2026. This indicates that the IDEAYA Biosciences, Inc. Common Stock has generated -38.64% annual rate of fall in its earning per share (EPS) in the last 4 quarters.